Publicaciones en las que colabora con Rosario Menéndez Villanueva (21)

2023

  1. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

    The Lancet Respiratory Medicine, Vol. 11, Núm. 7, pp. 637-649

  2. Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 772-778

  3. Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia (Intensive Care Medicine, (2023), 49, 6, (615-632), 10.1007/s00134-023-07033-8)

    Intensive Care Medicine

  4. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    Intensive Care Medicine, Vol. 49, Núm. 6, pp. 615-632

  5. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    European Respiratory Journal, Vol. 61, Núm. 4

  6. Machine-Learning Model for Mortality Prediction in Patients With Community-Acquired Pneumonia: Development and Validation Study

    Chest, Vol. 163, Núm. 1, pp. 77-88

  7. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

  8. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors

    Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82

2022

  1. Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 281-283

  2. Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis

    Archivos de Bronconeumologia, Vol. 58, Núm. 11, pp. 773-775

  3. Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 2, pp. 271-279

2021

  1. Correction to: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study (European Journal of Clinical Microbiology & Infectious Diseases, (2020), 39, 8, (1513-1525), 10.1007/s10096-020-03870-3)

    European Journal of Clinical Microbiology and Infectious Diseases

  2. Pneumonia

    Nature Reviews Disease Primers, Vol. 7, Núm. 1

  3. Understanding the host in the management of pneumonia: An official American thoracic society workshop report

    Annals of the American Thoracic Society, Vol. 18, Núm. 7, pp. 1087-1097

  4. Validation of a prediction score for drug-resistant microorganisms in community-acquired pneumonia

    Annals of the American Thoracic Society, Vol. 18, Núm. 2, pp. 257-265

2020

  1. Defining Community-Acquired Pneumonia as a Public Health Threat: Arguments in Favor from Spanish Investigators

    Medical sciences (Basel, Switzerland), Vol. 8, Núm. 1

  2. Systemic inflammation during and after bronchiectasis exacerbations: Impact of pseudomonas aeruginosa

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-15

2019

  1. Clinical factors associated with a shorter or longer course of antibiotic treatment in patients with exacerbations of bronchiectasis: A prospective cohort study

    Journal of Clinical Medicine, Vol. 8, Núm. 11

2017

  1. Pulmonary exacerbation in adults with bronchiectasis: A consensus definition for clinical research

    European Respiratory Journal, Vol. 49, Núm. 6

2015

  1. Bacterial Pneumonia and Lung Abscess

    Murray and Nadel's Textbook of Respiratory Medicine: Volume 1,2, Sixth Edition (Elsevier), pp. 557-582.e22